We embrace a “human-centric” approach to Health design. Involving and collaborating with our intended audiences. By doing so, we gain a deep understanding of their (in)direct needs and establish a clear view of the problems they face.

Systemic problems need a new way of interacting between stakeholders. We explore, define, co-design and deliver new joint-value opportunities in the Health Ecosystem. Always collaborating closely with both industry partners and consumers.

We combine insights gained from observing human behavior with technological opportunities. Identifying, designing and building innovative Digital Health solutions. These solutions grow the business and improve the quality of life of end-users.

We help companies in MedTech and Pharmaceuticals to shift from “Volume to Value”. Uncovering implied patient, clinical and non-clinical market needs. We test, validate and deliver value-based care strategies and market access roadmaps. 
All in close collaboration with global multidisciplinary teams.

Impactful health and disease education needs a high level of participation and engagement. At Made, we co-create clear and engaging educational materials. For increased well-being and therapy compliance, we involve patients and clinical stakeholders throughout the design process.

By involving patients, HCPs or industry stakeholders at the design table and building on these three pillars, Made co-designs and develops patient-centric pathways, medical products and experiences. Only through close cooperation, we can build solutions that patients and providers love.

A new level of creativity and collaboration is required to innovate successfully and take advantage of the promise of (digital) technologies while relieving pressure on limited resources.

The Made "Health Ecosystem Sprint" allows companies to explore joint-value propositions and powerful partnerships that have the potential to reshape and disrupt the industry.

We support companies in Pharma and Medtech with their global market value and access strategies by exploring, defining, capturing and conveying the value of medical products or services.

- How do patient journeys differ by patient segment, market or country?
- Who are the key clinical and non-clinical stakeholders and what is their decision-making process?
- What value proposition solves best for the different stakeholder needs?
- With what pricing strategy and at what price point might we capture the value that we have defined?

We are facing a Volume-to-Value Revolution where the health marketplace is being redesigned from the patient’s perspective.

Made enables corporate players to shift their strategy from “supplying products” to “providing solutions”, resulting in superior outcomes and care experiences.

We help you actionably tackle this unprecedented innovation opportunity to redefine your strategy “beyond the pill”.